Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Digital Pathology Market Share, Size, Trends, Industry Analysis & Forecasts Report, 2021-2028 -

November 12, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Nov 12, 2021--

The “Digital Pathology Market Share, Size, Trends, Industry Analysis Report, By Application; By End-Use; By Product; By Region; Segment Forecast, 2021 - 2028” report has been added to’s offering.

The global digital pathology market size is expected to reach USD 1.44 billion by 2028.

Advancements in micro-arrays and incorporation of predictive models using API algorithms and innovations in data analysis are expected to fuel the market growth for digital pathology. Rising preference towards computer-aided diagnosis which integrates image processing, mathematics, artificial intelligence, and machine learning to facilitate efficient disease diagnosis and helps in evaluating disease progression and risk assessment.


These benefits are projected to fuel demand in digital pathology systems in the forthcoming years. For instance, in April 2020, Leica Biosystems received approval for its Aperio AT2 DX Scanner and Web Viewer for remote diagnosis and Philips also received clearance for its IntelliSite Pathology services for remote diagnosis during emergencies.

Market participants operating in the digital pathology industry include Apollo Enterprise Imaging Corp., 3DHISTECH Ltd., ContextVision AB., Danaher, Corista, Glencoe Software, Inc, Huron Digital Pathology, Hamamatsu Photonics, Inc., Indica Labs, Inspirata, Inc., Koninklijke Philips, KONFOONG BIOTECH INTERNATIONAL CO., LTD, Objective Pathology Services, Mikroscan Technologies, Olympus Corporation, Proscia Inc., OptraScan, Roche Ltd., Visiopharm A/S, Sectra AB, and XIFIN, Inc.

International players such as Danaher, Huron Digital, and Hamamatsu Photonics held a majority of the market share of digital pathology. Companies in the marketplace are engaged in new product launches, mergers & acquisitions, and collaboration with small software data analysis companies to reap more benefits.

In this direction, Danaher Corporation to increase its footprint in Asia Pacific region in August 2020, introduced Aperio GT 450 DX.

Earlier, in September 2020, Philips helped in the digitization of histology slides at the US-based Oxford University Hospitals for its pathology department.

Moreover, previously in June 2018, Philips acquired Ireland-based Irish PathXL, one of the prominent players in image-based analysis. The acquisition was to integrate tools targeting different applications in image analysis, computational biology, and workflow solutions.

Digital Pathology Market Dynamics

Drivers and Opportunities


  • Advancements in healthcare digitization
  • Rising need for faster and real-time diagnosis

Restraints and Challenges

  • High upfront costs

Porter’s Five Forces Analysis

PESTLE Analysis

Digital Pathology Market Industry trends

COVID-19 Impact Analysis

Companies Mentioned

  • 3DHISTECH Ltd.
  • Apollo Enterprise Imaging Corp.
  • ContextVision AB.
  • Corista
  • Danaher
  • Glencoe Software Inc
  • Hamamatsu Photonics Inc.
  • Huron Digital Pathology
  • Indica Labs
  • Inspirata Inc.
  • Koninklijke Philips
  • Leica Biosystems Nussloch GmbH
  • Mikroscan Technologies
  • Objective Pathology Services
  • Olympus Corporation
  • OptraScan
  • Proscia Inc.
  • Roche Ltd.
  • Sectra AB
  • Visiopharm A/S
  • XIFIN Inc.

For more information about this report visit

View source version on


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 11/12/2021 09:29 AM/DISC: 11/12/2021 09:29 AM